Shanghai Junshi Biosciences Co., Ltd. (SHJBF)
- Previous Close
0.0000 - Open
1.2400 - Bid 1.5900 x --
- Ask 2.5900 x --
- Day's Range
1.2400 - 1.2400 - 52 Week Range
1.2400 - 1.9700 - Volume
2,037 - Avg. Volume
0 - Market Cap (intraday)
3.411B - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1800 - Earnings Date Mar 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.
www.junshipharma.comRecent News: SHJBF
View More
Performance Overview: SHJBF
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHJBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHJBF
View MoreValuation Measures
Market Cap
3.53B
Enterprise Value
3.53B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.23
Price/Book (mrq)
2.40
Enterprise Value/Revenue
13.62
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-59.68%
Return on Assets (ttm)
-7.16%
Return on Equity (ttm)
-21.15%
Revenue (ttm)
2.07B
Net Income Avi to Common (ttm)
-1.23B
Diluted EPS (ttm)
-0.1800
Balance Sheet and Cash Flow
Total Cash (mrq)
3.02B
Total Debt/Equity (mrq)
49.07%
Levered Free Cash Flow (ttm)
-760.21M